09.02.26 -- This Isn't Just A Compliance Exercise

As GLP-1 use expands, cardiovascular research is evolving. Discover key trial design considerations, development trends, and insights driving cardiometabolic innovation.

The real challenge with enrollment often comes at the screening stage, where PI prioritization, site bandwidth, and sponsor support guide how many patients actually make it onto a study.

As RTSM technology continues to evolve, clinical trial rescues are becoming increasingly common. Explore the rise of the rescue trend and why more sponsors are ready to change course.

Natalie Monegro argues that representative enrollment is a scientific imperative, not merely a compliance exercise, and explains why sponsors need to show how trial data will be used to support real-world treatment and commercialization.

Drawing on real-world experience and end-to-end capabilities, this presentation outlines actionable strategies to accelerate recruitment, boost predictability, and expand patient trial access.

Learn how protocol choices like AI, adaptive designs, and decentralized methods impact IRB review, participant protections, consent, and key regulatory requirements in clinical research.

PK tools can do more than model drug behavior — they shape smarter trial designs, better dosing decisions, and lighter burdens on patients. Here's how.